Obalon Therapeutics, Inc. (OBLN) News

Obalon Therapeutics, Inc. (OBLN): $3.05

-0.19 (-5.86%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter OBLN News Items

OBLN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

OBLN News Highlights

  • 500 - Internal server error
  • Over the past 21 days, the trend for OBLN's stories per day has been choppy and unclear. It has oscillated between 3 and 6.

Latest OBLN News From Around the Web

Below are the latest news stories about Obalon Therapeutics Inc that investors may wish to consider to help them evaluate OBLN as an investment opportunity.

Hedge Funds Are Betting On Obalon Therapeutics, Inc. (OBLN)

No summary available.

Insider Monkey | June 14, 2021

Is Obalon Therapeutics, Inc. (OBLN) Going to Burn These Hedge Funds?

No summary available.

Insider Monkey | June 14, 2021

DGAP-News: ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger

DGAP-News: ReShape Lifesciences Inc. / Key word(s): Merger ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger 08.06.2021 / 13:30 The issuer is solely responsible for the content of this announcement. ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending

Wallstreet:Online | June 8, 2021

ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger

SAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 8, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS) and Obalon Therapeutics, Inc.

Yahoo | June 8, 2021

ReShape Lifesciences Inc., US67424L2097

Reminder: Obalon Therapeutics, Inc. Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences Inc

Ad Hoc News | May 24, 2021

ReShape Lifesciences Inc.: Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences

SAN DIEGO, CA / ACCESSWIRE / May 24, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled i

FinanzNachrichten | May 24, 2021

DGAP-News: Reminder: Obalon Therapeutics, Inc. Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences Inc

DGAP-News: ReShape Lifesciences Inc. / Key word(s): Miscellaneous Reminder: Obalon Therapeutics, Inc. Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences Inc 24.05.2021 / 13:35 The issuer is solely responsible for the content of this announcement. Reminder: Obalon Therapeutics

Wallstreet:Online | May 24, 2021

Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences

Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity, is taking this opportunity to remind its stockholders to vote on all the proposals related to the proposed merger with ReShape Lifesciences Inc. in advance of the upcoming reconvened special meeting of Obalon stockholders n

BioSpace | May 23, 2021

ReShape Lifesciences Inc.: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences

SAN DIEGO, CA / ACCESSWIRE / May 21, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled i

FinanzNachrichten | May 21, 2021

Obalon Therapeutics Stockholders Special Meeting Adjourned to May 25, 2021

Urging all Shareholders to Vote For Proposals Related to Merger with ReShape LifeSciences Inc.Meeting to be held via Webcast at 8:30 a.

Yahoo | May 18, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6159 seconds.